Stock 2348 DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Dawnrays Pharmaceutical (Holdings) Limited

Equities

2348

KYG2687M1006

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:00 2024-05-03 am EDT 		5-day change 1st Jan Change
1.18 HKD +0.85% Intraday chart for Dawnrays Pharmaceutical (Holdings) Limited +0.85% +12.38%
Mar. 26 Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 CI
Mar. 25 Dawnrays' 2023 Profit Falls 9% on Lower Revenue MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dawnrays Pharmaceutical : Form of proxy for use at the Annual General Meeting of the Company to be held on Friday, 28 May 2021 (or at any adjournment thereof)
PU
Dawnrays Pharmaceutical : PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
PU
Dawnrays Pharmaceutical : Next Day Disclosure Return
PU
Dawnrays Pharmaceutical : Next Day Disclosure Return
PU
Dawnrays Pharmaceutical : Next Day Disclosure Return
PU
Dawnrays Pharmaceutical : Next Day Disclosure Return
PU
Dawnrays Pharmaceutical : Next Day Disclosure Return
PU
Dawnrays Pharmaceutical : Next Day Disclosure Return
PU
Dawnrays Pharmaceutical : Next Day Disclosure Return
PU
Dawnrays Pharmaceutical : SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2019 ANNUAL REPORT
PU
Dawnrays Pharmaceutical : DISCLOSEABLE TRANSACTION-CONSTRUCTION AGREEMENTS
PU
Dawnrays Pharmaceutical : Announcement of Interim Results for the six months ended 30 June 2017
PU
Dawnrays Pharmaceutical : CHANGE IN BOARD LOT SIZE
PU
Dawnrays Pharmaceuti : List of Directors and their Role and Function
PU
Dawnrays Pharmaceuti : Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2011, Net Profit after Tax Dropped 12.3% to RMB 146.31 Million, A Final Dividend of HK$ 0.068 per Share was Declared
PU
Dawnrays Pharmaceuti : Date of Board Meeting
PU
Dawnrays Pharmaceuti : Voluntary Announcement New Product Pharmaceutical Registration Approval
PU
Dawnrays Pharmaceuti : Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2011: Net Profit after Tax Jumped 2.9% to RMB 90.06 Million, an Interim Dividend of HK$ 0.02 per Share was Declared
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2348 Stock
  4. News Dawnrays Pharmaceutical (Holdings) Limited
  5. Press Releases